Vascular closure devices are required for the procedures following catherization to achieve hemostasis of the small hole created in the artery. Arterial closure devices (ACDs) are the most preferred vascular closure devices introduced in 1995 to reduce bed rest, time, pain, and discomfort associated with the mechanical compression technique. This helps in reduction of vascular complications and also decreases the time to hemostasis and ambulation. Mechanical compression technique was considered the gold standard before the introduction of vascular closure devices. Vascular closure devices are widely used in diagnostic and interventional procedures due to advantages such as reduced hemostasis and ambulation and increased patient comfort over the mechanical compression technique.
Obtain Report Details @ https://www.transparencymarketresearch.com/arteriotomy-closure-devices-market.html
An arterial closure device (ACD) along with a deployment tool comprises an arterial closure system. ACD is deployed within the contacting site vessel with the help of deployment tool. Arterial closure devices (ACDs) are of two types: active closure devices and passive closure devices. Active closure devices include suture devices, collagen plug devices, and clips. Passive closure devices are helpful for providing mechanical compression with enhanced hemostasis. These include hemostasis pads and compression devices such as FemoStop, Boomerang, Safeguard, Chito-Seal, and D-Stat.
Increasing geriatric population due to advancement in health care techniques, rising need of endovascular procedures, reduced complications with the use of ACDs, reimbursement of diagnostic procedures involved, and comfort to the patients are the factors driving the arterial closure devices (ACDs) market. However, less adoption in developing countries, increased cost of implantable arterial devices, and high incidence of leg ischemia are the factors restraining the market.
Request For Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=29861
The arteriotomy closure devices (ACDs) market has been segmented based on type of device, application, and region. In terms of type of device, the market has been segmented into passive closure devices and active closure devices. Passive closure devices include devices that assist in the mechanism of compression such as clamps/tamping devices, assisted coagulation, and sealants. Active closure devices include devices involved in immediate closure including collagen plug, sutures, polyglycolic acid devices, and extravascular clips. Collagen plug devices can be further categorized into angioseal and vasoseal. In terms of application, ACDs can be segmented to be used for procedures carried out by femoral arterial access and for procedures carried out by transradial arterial access. Femoral arterial access is the most widely used technique; however, increased interest in transradial arterial access has been observed as it reduces bleeding complications.
Request For Custom Research @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=29861
Geographically, the global ACDs market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is the leading market for arteriotomy closure devices due to advancement in technology, involvement of diagnostic technique as reimbursement and increase in the need of vascular procedures. However, the ACDs market in some developing countries in Asia Pacific and Africa are likely to witness sluggish growth due to lack of health care advancements and adoption of complicated expensive techniques.
Pre Book A Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=29861<ype=S
Key market players in the arteriotomy closure devices market include Abbott Vascular, Cardiva Medical, Arstatis, Cardinal Health, St. Jude Medical, Morris Innovative Research, and Scion BioMedical.
More Trending Reports by Transparency Market Research –
- Medical Sensors Market: https://www.biospace.com/article/medical-sensors-market-to-expand-at-a-cagr-of-9-9-percent-from-2018-to-2026-rising-application-in-different-medical-areas-benefiting-industry-growth/
- 3D Bioprinting Market: https://www.biospace.com/article/3d-bioprinting-market-a-new-dawn-of-technology-promises-robust-growth/
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453